Profile
Axel Ullrich is the founder of SciRhom GmbH, founded in 2016.
Dr. Ullrich was the founder of Evotec (München) GmbH, founded in 2005, and served as Member-Supervisory Board from 2005 to 2009.
Dr. Ullrich is also the founder of Sugen, Inc.,Axxima Pharmaceuticals AG,NEO New Oncology GmbH,U3 Pharma AG..
Dr. Ullrich is Director-Supervisory Board at Max-Planck-Institute for Molecular Genetics since 2009.
Former jobs include Non-Executive Director at Cryptome Pharmaceuticals Ltd. and Scientist at Genentech, Inc. from 1978 to 1988.
Axel Ullrich active positions
| Companies | Position | Start |
|---|---|---|
Max-Planck-Institute for Molecular Genetics
Max-Planck-Institute for Molecular Genetics Other Consumer ServicesConsumer Services Functions as a College/University | Director/Board Member | - |
SciRhom GmbH
SciRhom GmbH BiotechnologyHealth Technology Operates as a pioneering biotech enterprise specialized in developing therapeutic antibodies | Founder | 01/01/2016 |
Former positions of Axel Ullrich
| Companies | Position | End |
|---|---|---|
NEO New Oncology GmbH
NEO New Oncology GmbH Medical/Nursing ServicesHealth Services Designs and develops diagnostic platform | Founder | 07/04/2022 |
Axxima Pharmaceuticals AG
Axxima Pharmaceuticals AG Miscellaneous Commercial ServicesCommercial Services Researches and develops drugs | Founder | 05/02/2009 |
Cryptome Pharmaceuticals Ltd.
Cryptome Pharmaceuticals Ltd. BiotechnologyHealth Technology Discovers and develops effective and safe protein-derived medicines | Director/Board Member | 05/04/2006 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Corporate Officer/Principal | 01/01/1988 |
Sugen, Inc.
Sugen, Inc. Pharmaceuticals: MajorHealth Technology Develops small molecule drugs and related pharmaceutical products | Founder | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 9 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Sugen, Inc.
Sugen, Inc. Pharmaceuticals: MajorHealth Technology Develops small molecule drugs and related pharmaceutical products | Health Technology |
Cryptome Pharmaceuticals Ltd.
Cryptome Pharmaceuticals Ltd. BiotechnologyHealth Technology Discovers and develops effective and safe protein-derived medicines | Health Technology |
Axxima Pharmaceuticals AG
Axxima Pharmaceuticals AG Miscellaneous Commercial ServicesCommercial Services Researches and develops drugs | Commercial Services |
U3 Pharma AG
U3 Pharma AG Miscellaneous Commercial ServicesCommercial Services Researches and develops novel targeted therapeutics used for cancer treatment | Commercial Services |
Max-Planck-Institute for Molecular Genetics
Max-Planck-Institute for Molecular Genetics Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Evotec (München) GmbH
Evotec (München) GmbH Chemicals: Major DiversifiedProcess Industries Provides manufacturing and research support services for pharmaceutical and biotechnology companies | Process Industries |
NEO New Oncology GmbH
NEO New Oncology GmbH Medical/Nursing ServicesHealth Services Designs and develops diagnostic platform | Health Services |
SciRhom GmbH
SciRhom GmbH BiotechnologyHealth Technology Operates as a pioneering biotech enterprise specialized in developing therapeutic antibodies | Health Technology |
- Stock Market
- Insiders
- Axel Ullrich
















